The aim of modern keratoconus treatment is to improve visual acuity and to stop the progression of the disease.
MyoRing: To improve visual acuity.
The MyoRing is a crucial milestone in the treatment of keratoconus. MyoRing treatment is currently the most modern technology in this field....
KERALUX Crosslinking: With still good visual acuity.
Keralux is currently the most modern crosslinking technology for stopping the progression of the keratoconus with good visual acuity and eliminates the usual sources of error in crosslink treatment such as head movements, eye movements and variation of the corneal steepness.
... the latest technology for the treatment of keratoconic eyes where visual acuity is already impaired.
CISIS/MyoRing is the first and only technology which can achieve an improvement of vision and a termination of the progression of the disease. It is as permanent as laser treatment and as safe as contact lenses.
In keratoconic eyes suffering from already impaired vision, MyoRing treatment can improve the vision significantly. MyoRing is a complete ring made for an implantation into the cornea with the ability to eliminate irregularities within the diseased cornea. Due to its patented design as a complete ring implant, the MyoRing can also support the weakened cornea and therefore stop the progression of the disease.
The treatment is a short and minimally-invassive procedure performed under topical anesthesia (eye drops) only. It is free of pain (pre-operatively as well as post-operatively) and the tiny wound heals within a few hours without the need of a suture. No eye patch. No suture. MyoRing keratoplasty is among the safest surgical procedures in ophthalmology and can replace both contact lenses and corneal transplants in most cases.
... the latest technology for the treatment of keratoconic eyes where the disease is progressing but visual acuity is still sound.
KERALUX Crosslinking allows a homogenous energy transfer even in the steepest and most affected areas of the cornea.
Safe and effective: Conventional corneal crosslinking is a globally accepted therapy of keratoconus. The intention of corneal crosslinking is to stop the progression of the disease by stiffening the cornea. In order to achieve this, 5.4 J/cm2 of energy have to be transferred to the corneal tissue via UV-A light irradiation. In conventional crosslinking, the effective energy transferred to a certain point of the cornea depends on its steepness. Since the steepness of the cornea varies in keratoconic eyes and from patient to patient, conventional crosslinking is not able to provide the right amount of UV-A irradiation to all parts of the cornea. Unfortunately, this is particularly true for the steepest and most affected areas of the cornea. Treatment failure rates of up to 15% are reported.
KERALUX Crosslinking is a new technology, which is able to ensure a homogenous UV-A energy transfer to all parts of the cornea, independent from its steepness. This is achieved by an irradiation channel, which reflects the UV-A irradiation and guarantees a homogenous energy transfer, rather than a free irradiation path used in conventional crosslinking.
Keratoconus is a rare condition. The MyoRing treatment in Germany is currently only carried out in Munich and Hamburg. Therefore, patients often have to travel from far away to clarify whether CISIS / MyoRing treatment is possible. Dr. Daxer, the specialist for treatment in Munich, now offers the opportunity to conduct a detailed discussion of the findings and the informational discussion telemedically using a video conference between the patient and Dr. Daxer. The patient must first collect the following examination data from his ophthalmologist on site: 1. Visual acuity with and without correction 2. Refraction 3. Pentacam images with corneal thickness and K values. This saves the patient the long journey! If the telemedical consultation leads to the result that CISIS / MyoRing treatment is possible and sensible, an appointment for an intervention with Dr. Daxer can be arranged in Munich. Immediately before the intervention, the examination data are precisely determined and checked and checked with Dr. Daxer discussed. Inquiries for telemedical advice from Dr. Daxers can be contacted by email at firstname.lastname@example.org, via the contact form on this website or by phone on 0800 222 78 66 (Mon - Thu from 8.30 a.m. to 12.30 p.m.).